ENTITY
Aurobindo Pharma

Aurobindo Pharma (ARBP IN)

160
Analysis
Health Care • India
Aurobindo Pharma is an Indian multinational pharmaceutical manufacturing company that develops, manufactures, and commercializes a wide range of generic pharmaceuticals, active pharmaceutical ingredients (APIs), and specialty formulations. The company's product portfolio covers therapeutic areas including antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterologicals, anti-allergics, oncology, and dermatology. It commenced operations in 1988-1989 with a single unit manufacturing semi-synthetic penicillin in Puducherry. Headquartered in Hyderabad, Telangana, India, the company was founded in 1986.
more
•29 Jul 2026 13:26

Aequitas: Juniper Green Energy IPO - RHP Updates, Peer Comp and Thoughts on Valuation

Juniper Green Energy is looking to raise about US$187m in its downsized India IPO. In this note, we talk about the RHP updates and implied...

Logo
180 Views
Share
bullish•Sudeep Pharma
•09 Jul 2026 08:30

Sudeep Pharma: Building From Specialty Ingredients to Battery Materials

​Sudeep Pharma reports strong FY26 revenue and PAT, with focus on specialty ingredients and growth levers for the future. Margin recovery and...

Logo
124 Views
Share
•29 Feb 2020 19:07

COVID-19 : A Viral Threat to Pharma Supply Chain

Corona Virus shadows are glooming all over the world, and these fears have just begun. As a major highlight of 2020, the virus has conquered the...

Logo
570 Views
Share
•10 Oct 2018 15:26

Para IV Winners and Losers - September 2018

This month’s Para IV developments suggest that there is likely to be benefit to Teva Pharmaceutical Sp Adr (TEVA US) on Vesicare, Soolantra and...

Logo
588 Views
Share
•07 Jun 2018 21:45

Para IV Winners & Losers - May 2018

This month’s Para IV developments suggest that there is likely to be benefit to Amneal Pharmaceuticals Inc (AMRX US) on Lialda, BioQ pharma for...

Logo
215 Views
Share
x